Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe PneumoniaOlivier Hermine, Robin Charreteur, Raphaël Porcher et al.|JAMA Internal Medicine|2020Cited by 777
Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trialPierre‐Louis Tharaux, Robin Charreteur, Gilles Pialoux et al.|The Lancet Respiratory Medicine|2021Cited by 297